2000
DOI: 10.1152/ajpendo.2000.278.3.e553
|View full text |Cite
|
Sign up to set email alerts
|

Protein kinase C modulates insulin action in human skeletal muscle

Abstract: There is good evidence from cell lines and rodents that elevated protein kinase C (PKC) overexpression/activity causes insulin resistance. Therefore, the present study determined the effects of PKC activation/inhibition on insulin-mediated glucose transport in incubated human skeletal muscle and primary adipocytes to discern a potential role for PKC in insulin action. Rectus abdominus muscle strips or adipocytes from obese, insulin-resistant, and insulin-sensitive patients were incubated in vitro under basal a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
64
0

Year Published

2002
2002
2013
2013

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 91 publications
(64 citation statements)
references
References 45 publications
(46 reference statements)
0
64
0
Order By: Relevance
“…PKC activity is increased in tissues from obese Zucker rats. In liver this increase appears to be the result of an increase in the membrane content of PKC isoforms , ,´and , (Considine et al 1995, Qu et al 1999, while in skeletal muscle this increase has been ascribed to an elevation in the membrane content of PKC isoforms (Cortright et al 2000) and´ (Avignon et al 1996). In the current study, we have demonstrated that IR Ser 994 is an in vitro phosphorylation target for PKC.…”
Section: Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…PKC activity is increased in tissues from obese Zucker rats. In liver this increase appears to be the result of an increase in the membrane content of PKC isoforms , ,´and , (Considine et al 1995, Qu et al 1999, while in skeletal muscle this increase has been ascribed to an elevation in the membrane content of PKC isoforms (Cortright et al 2000) and´ (Avignon et al 1996). In the current study, we have demonstrated that IR Ser 994 is an in vitro phosphorylation target for PKC.…”
Section: Discussionmentioning
confidence: 95%
“…In PKC-mediated insulin-resistant states such as obesity or conditions of elevated lipid availability, both a tissue and isoform-selective PKC activation has been detected (Avignon et al 1996, Griffin et al 1999, Cortright et al 2000. PKC activity is increased in tissues from obese Zucker rats.…”
Section: Discussionmentioning
confidence: 99%
“…In muscle, a short-term infusion of Intralipid (a fatty acid emulsion comprised of a mixture of fatty acids, including linoleic, oleic, and palmitic acid) impairs insulin-stimulated glucose disposal, and this is thought to be due to increased activation of PKC-θ, the most abundant of the novel class of PKC isoforms in skeletal muscle (23)(24)(25)(26)(27), with a consequent decrease in insulin-stimulated IRS-1 tyrosine phosphorylation and PI3K activity (5)(6)(7)28). Based on these data from peripheral tissues, we hypothesize that PKC-θ is a critical mediator of fatty acid-induced central insulin and leptin resistance.…”
Section: Introductionmentioning
confidence: 99%
“…The increase in IMCL-TG occurred several hours after the elevation of plasma FFA levels and coincided with the development of insulin resistance (10), suggesting that an insulin resistance-causing signal was generated during the synthesis (or the breakdown) of IMCL-TG. We hypothesize that diacylglycerol (DAG) may be such a signal because an increase in its synthesis would coincide with that of triglycerides (11) and because it is a well-known allosteric activator of protein kinase C (PKC) (12)(13)(14), an enzyme that has been linked to insulin resistance in muscle in a wide variety of rodent models (11,15,16), including rats infused with lipid (17) and massively obese humans (18,19). To evaluate this possibility, DAG mass and PKC activity and distribution were assayed in skeletal muscle biopsies obtained from normal human volunteers in whom insulin resistance was produced by raising plasma FFA levels during a euglycemic-hyperinsulinemic clamp.…”
mentioning
confidence: 99%